Source oral administration ferrous sulfate and folic acid tablets for Anemia, Pregnancy, and Deficiency

Oral Administration Ferrous Sulfate and Folic Acid Tablets Sourcing Guide

Sourcing ferrous sulfate and folic acid tablets requires a disciplined approach to verifying pharmaceutical-grade manufacturing, particularly when dealing with complex formulations that address nutritional deficiencies. The core keyword for this procurement category is oral administration ferrous sulfate and folic acid tablets, which indicates a specific therapeutic application aimed at treating conditions such as anemia or supporting prenatal health through targeted nutrient supplementation. Buyers must navigate a market where products are often listed under broader categories like "Vitamins and Minerals Deficiency Drug" or "Nutritional Therapeutics," necessitating careful cross-referencing of product attributes to ensure the active ingredients match the required therapeutic profile.

The procurement landscape for these tablets is characterized by a wide variance in listing signals, including observed price ranges from zero to three thousand five hundred USD and minimum order quantities (MOQs) spanning from one unit to one million units. This disparity suggests that listings may represent everything from small-scale sample orders to bulk industrial supply contracts. Consequently, buyers must distinguish between genuine pharmaceutical-grade offerings and generic nutritional supplements by scrutinizing the stated grade standards, such as Medicine Grade or specific pharmacopeial standards like Cp and Bp, rather than relying solely on the product title or initial price points.

Product Scope and Observed Listing Signals

The product scope for ferrous sulfate and folic acid tablets typically encompasses formulations designed for the treatment of mild to moderately severe infections or, more commonly in this context, the correction of vitamin and mineral deficiencies. Observed listing signals indicate that these products are often categorized under organic chemicals or biological products, reflecting the dual nature of their composition. Buyers should verify that the product description explicitly mentions the combination of iron and folic acid, as some listings may only reference one component or use generic terms like "complex" or "analysis reagent," which do not guarantee the presence of the necessary therapeutic agents for oral administration.

Listing attributes frequently highlight customization options, with many suppliers supporting OEM and ODM services to tailor packaging and formulation for specific markets. The observed data shows that products are available in various shapes, predominantly tablets, and are suitable for adults, children, and the elderly, indicating a broad target demographic. However, buyers must be cautious of listings that describe the product as an "analysis reagent" or "organic chemical" without clear pharmaceutical application details, as these terms may indicate laboratory-grade materials rather than finished dosage forms intended for human consumption.

Technical Specifications to Verify

Technical verification begins with confirming the dosage strength and physical form of the tablets, as observed specifications include models such as 60mg, 200mg, and 5mg, alongside packaging formats like 10x10 tablets per box or 100 tablets per tin. Buyers must ensure that the stated dosage aligns with the therapeutic requirements for ferrous sulfate and folic acid, as incorrect dosages can lead to ineffective treatment or adverse effects. The physical state is consistently listed as solid and non-volatile, which is standard for tablet formulations, but the specific weight and count per package must be validated against the purchase order to prevent discrepancies in supply volume.

Packaging standards and dimensions are critical for logistics and storage planning, with observed data indicating carton dimensions of 553530 CM and various internal packaging methods such as blister packs with boxes or direct carton packing. Buyers should verify that the packaging material is suitable for protecting the tablets from moisture and light, which can degrade the potency of iron and folic acid. Additionally, the shelf life is typically listed as three years, but this must be confirmed for each specific batch and packaging type, as improper storage conditions can significantly reduce the effective lifespan of the product.

Compliance and Safety Documentation

Compliance with Good Manufacturing Practice (GMP) is a non-negotiable requirement for sourcing pharmaceutical-grade ferrous sulfate and folic acid tablets. The observed data confirms that GMP certification is a key attribute for many suppliers, indicating adherence to quality control standards during production. Buyers must request valid GMP certificates from the manufacturer and verify their authenticity with the relevant regulatory bodies in the country of origin, which is often listed as China or P. R. China. This certification ensures that the manufacturing environment, processes, and personnel meet the necessary standards for producing safe and effective medicinal products.

In addition to GMP, buyers should verify compliance with specific pharmacopeial standards such as Chinese Pharmacopoeia (Cp) and British Pharmacopoeia (Bp), which are listed as available standards for many products. These standards define the purity, potency, and quality requirements for the active ingredients and the final dosage form. Buyers must ensure that the product documentation includes test results or certificates of analysis (COA) that demonstrate compliance with these standards, particularly for heavy metal limits, dissolution rates, and assay accuracy, to guarantee the safety and efficacy of the tablets for oral administration.

Cost Drivers and Commercial Terms

Cost drivers for ferrous sulfate and folic acid tablets include the complexity of the formulation, the scale of production, and the level of customization required. Suppliers offering OEM/ODM services may charge additional fees for custom packaging, labeling, or formulation adjustments, which can impact the final unit price. The observed price range of 0-3500 USD likely reflects variations in order quantity, with bulk orders benefiting from economies of scale, while smaller orders or customized batches may carry higher per-unit costs. Buyers should request detailed quotations that break down costs for raw materials, manufacturing, packaging, and logistics to understand the true cost structure.

Commercial terms and payment conditions are also significant factors in the procurement process, with observed data indicating terms such as FOB (Free on Board) and CIF (Cost, Insurance, and Freight), as well as payment methods like T/T (Telegraphic Transfer) and L/C (Letter of Credit). Delivery times typically range from 30 to 60 days, which buyers must factor into their supply chain planning to avoid stockouts. It is essential to negotiate clear terms regarding shipping responsibilities, insurance coverage, and liability for delays, ensuring that the total landed cost is accurately calculated and aligned with the budget.

Supplier Qualification and Quality Control

Supplier qualification involves a thorough assessment of the manufacturer’s capabilities, including their production capacity, quality management systems, and track record in the pharmaceutical industry. Buyers should conduct on-site audits or request third-party audit reports to verify that the supplier’s facilities meet GMP standards and have the necessary equipment for chemical synthesis and tablet compression. The observed data indicates that many suppliers support OEM/ODM, suggesting flexibility in production, but buyers must ensure that this flexibility does not compromise quality control processes or consistency in product performance.

Quality control measures should include regular testing of raw materials, in-process checks, and final product analysis to ensure compliance with specified standards. Buyers should require suppliers to provide detailed quality control protocols, including methods for testing ferrous sulfate and folic acid content, dissolution profiles, and stability testing results. Establishing a clear communication channel for quality issues and defining acceptance criteria for batch releases is crucial for maintaining product integrity and ensuring that the tablets meet the required therapeutic standards for oral administration.

Long-Term Procurement Checks

Long-term procurement success depends on establishing robust supplier relationships and implementing continuous monitoring of product quality and supply chain reliability. Buyers should conduct periodic reviews of supplier performance, including on-time delivery rates, quality consistency, and responsiveness to issues. Regular re-verification of GMP certification and pharmacopeial compliance is essential, as regulatory requirements and manufacturing practices may evolve over time. Maintaining up-to-date documentation and fostering open communication with suppliers helps to mitigate risks and ensure a stable supply of ferrous sulfate and folic acid tablets.

Additionally, buyers should stay informed about changes in regulatory standards and market trends that may impact the sourcing of these tablets. This includes monitoring updates to Cp and Bp standards, as well as any new requirements for nutritional therapeutics or organic chemicals. By proactively adapting to these changes and maintaining a diversified supplier base, buyers can ensure continuity of supply and compliance with evolving regulatory landscapes, securing a reliable source of high-quality oral administration ferrous sulfate and folic acid tablets for their customers.